SCHEMBL23686705

SCHEMBL23686705

Cc1cnc(C(=O)NCc2ccc(OCc3ccccc3F)cc2)cn1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.65
▸ CYP1A2 P05177 1/20 0.65
▸ POLB P06746 1/20 0.65
▸ CYP3A4 P08684 1/20 0.65
▸ CYP2C9 P11712 1/20 0.65
▸ HPGD P15428 1/20 0.65
▸ CYP2C19 P33261 1/20 0.65
▸ ATM Q13315 1/20 0.65
▸ L3MBTL1 Q9Y468 1/20 0.65
▸ SCN3A Q9NY46 1/20 0.54
▸ SCN9A Q15858 1/20 0.53
▸ TSHR P16473 1/20 0.51
▸ NPSR1 Q6W5P4 1/20 0.51
▸ SMN1; SMN2 Q16637 2/20 0.50
▸ NPC1 O15118 1/20 0.50
▸ MAOB P27338 4/20 0.49
▸ KDM4E B2RXH2 1/20 0.47
▸ TP53 P04637 1/20 0.47
▸ ALOX12 P18054 1/20 0.47
▸ PARP15 Q460N3 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21580096 0.85 SCN3A (0.54) ALDH1A1CYP1A2POLBCYP3A4CYP2C9
SCHEMBL21580127 0.81 SCN3A (0.52) ALDH1A1CYP1A2POLBCYP3A4CYP2C9
SCHEMBL21580116 0.81 SCN3A (0.51) HPGDSCN3ASCN9ASMN1; SMN2MAOB
SCHEMBL21580134 0.80 SCN3A (0.55) ALDH1A1SCN3ASCN9ASMN1; SMN2MAOB
SCHEMBL21580107 0.79 SCN3A (0.52) ALDH1A1HPGDSCN3ASCN9ASMN1; SMN2
SCHEMBL21580137 0.79 SCN3A (0.54) ALDH1A1SCN3ASCN9ASMN1; SMN2NPC1
SCHEMBL12838360 0.79 ALDH1A1 (0.71) ALDH1A1CYP1A2POLBCYP3A4CYP2C9
SCHEMBL21580166 0.78 L3MBTL1 (0.51) ALDH1A1HPGDL3MBTL1SCN3ASCN9A
SCHEMBL21580126 0.78 SCN3A (0.56) ALDH1A1POLBSCN3ASCN9ASMN1; SMN2
SCHEMBL21580123 0.77 TSHR (0.57) HPGDSCN3ASCN9ATSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210230157-A1 PAIN TREATING COMPOUNDS AND USES THEREOF BIONOMICS LIMITED (AU) 2021-07-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210230157-A1 PAIN TREATING COMPOUNDS AND USES THEREOF TRPV1, TRPA1, TRPV3 ALDH1A1 768/4885CYP1A2 2613/4885POLB 4671/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback